The following points are a high-level overview, not a complete list of risks or precautions
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
Yes - through licensed pharmacies that require a valid prescription
Weight loss medications such as Wegovy, Mounjaro, Saxenda, and Orlistat help reduce appetite, regulate glucose levels, and support weight loss goals
A generic drug contains the same active ingredient as its brand-name version but tends to cost less
For women using estrogen-containing or progestin-only oral contraceptives, Topiramate may reduce contraceptive efficacy